# Cyclerion Therapeutics: Biotechnology, Cambridge, United States

> Cyclerion Therapeutics: Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology. Based in Cambridge, United States.

Source: https://millionrounds.com/startup/cyclerion-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Cyclerion Therapeutics

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Funding reported Last round: Post-IPO Equity

Biotechnology Cambridge, United States

Company summary

- **Founded:** 2019 7 years old
- **Team:** - not reported
- **Funding reported:** $222M in dollars
- **Last round:** Post-IPO Equity May 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Cyclerion Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Cyclerion Therapeutics raised

Funding, as reported

Reported in all **$222M** in dollars

Rounds **4**

Last round **Post-IPO Equity**

Last round date **May 2023**

Investors listed **5**

SEC Form D **$222M sold, 4 filings, last May 2023**

## Founders and team

From Cyclerion Therapeutics's own website and the SEC filings it signed: 12 on the team.

- **Jonathan Violin** Chief Executive Officer
- **Gan Wei** Chief Technology Officer
- **Mark Vignola** Chief Financial Officer
- **Matthew Leoni** Chief Medical Officer
- **Andrew Gottesdiener** Director
- **Heidi Henson** Director
- **Michelle Pernice** Director
- **Nimish Shah** Director
- **Tomas Kiselak** Chairman
- **Anjeza M. Gjino** Executive Officer i
- **Cheryl M. Gault** Executive Officer i
- **Peter M. Hecht** Director, Executive Officer i

On the board, as filed i *Errol M. De Souza* *Ole M. Isacson* *Steven M. Hyman* *Terrance M. McGuire*

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Cyclerion Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)